Skip to content

Pharmacokinetics study of food ingredient

Pharmacokinetics study of food ingredient - Pharmacokinetics study of food ingredient

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061419
Enrollment
28
Registered
2026-05-12
Start date
2026-05-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Food 4 intake Food 2 intake -&gt
Food 4 intake -&gt
Food 2 intake Food 4 intake -&gt

Sponsors

Suntory Holdings Limited
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Males who are 20 years of age or older at the time of obtaining consent and under 65 years of age at the end of the intake period (2) Individuals whose BMI at the screening test is 18.5~30 (3) Individuals who are not receiving any medical treatment at the time of study participation (4) Individuals who are able to visit the designated facility on the scheduled visit days (5) Individuals who fully understand the purpose and details of this study and provide written informed consent

Exclusion criteria

Exclusion criteria: (1) Individuals whose systolic blood pressure at the screening test is below 90 mmHg (2) Individuals who have donated (or are scheduled to donate) 200 mL or more of blood, either as component donation or whole blood, from 4 weeks before the start of the study until the study begins (3) Individuals who have donated (or are scheduled to donate) 400 mL or more of whole blood from 12 weeks before the start of the study until the study begins (4) Individuals whose total blood donation volume from the month 12 months prior to the study start up to the study start, plus the planned total blood collection volume for this study, exceeds 1,200 mL (5) Individuals who are currently participating in another study as study subjects, who have participated in another study within 4 weeks after its completion, or who plan to participate in another study during the study period (6) Individuals with a history of serious diseases (7) Individuals who are receiving any kind of medical treatment at the time of the screening test (8) Individuals with reduced renal function (9) Individuals with severe drug or food allergies (10) Individuals who have previously experienced discomfort or deterioration of physical condition due to blood collection (11) Individuals for whom venous blood collection from peripheral veins is difficult (12) Individuals whose average daily alcohol consumption exceeds 60 g of pure alcohol (13) Individuals who smoke or have quit smoking for less than 3 months (14) Individuals with extremely irregular eating habits (15) Individuals who work in shifts or work night shifts (16) Individuals who are judged by the principal investigator or sub-investigator to be unsuitable as study subjects

Design outcomes

Primary

MeasureTime frame
Pharmacokinetic parameters

Countries

Japan

Contacts

Public ContactMASAYUKI IDA

Suntory Holdings Limited Innovation Planning Department

Masayuki_Ida@suntory.co.jp050-1804-0336

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026